Chugai Pharma reported JPY28.41B in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Astellas Pharma JPY 197B 14.32B Jun/2025
Chugai Pharma JPY 28.41B 5.17B Jun/2025
Daiichi Sankyo JPY 180.35B 27.86B Jun/2025
Eisai JPY 100.16B 6.34B Jun/2025
Kyowa Hakko Kirin JPY 40.78B 1.26B Jun/2025
M3 JPY 26.06B 170M Jun/2025
Otsuka Holdings JPY 239.48B 6.99B Jun/2025
Shionogi JPY 25.82B 2.87B Jun/2025
Sumitomo Dainippon JPY 35.66B 13.91B Jun/2025
Takeda JPY 255.89B 39.98B Jun/2025
Terumo JPY 91.98B 8.58B Jun/2025